Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population

被引：0

作者：

van Zeijl, M. C. T. ^{[1
]}

Wouters, M. W. J. M. ^{[2
]}

van den Eertwegh, A. J. ^{[3
]}

Aarts, M. J. ^{[4
]}

van Akkooi, A. C. J. ^{[2
]}

van den Berkmortel, F. W. P. J. ^{[5
]}

Franken, M. G. ^{[6
]}

de Groot, J. W. B. ^{[7
]}

Herbschleb, K. H. ^{[8
]}

van der Hoeven, J. J. M. ^{[8
]}

Hospers, G. A. P. ^{[9
]}

Kapiteijn, E. ^{[1
]}

Piersma, D. ^{[10
]}

van Rijn, R. S. ^{[11
]}

Suijkerbuijk, K. P. M. ^{[12
]}

Ten Tije, A. J. ^{[13
]}

Van der Veldt, A. A. M. ^{[14
]}

Vreugdenhil, G. ^{[15
]}

Haanen, J. B. A. G. ^{[2
]}

机构：

[1] Leiden Univ, Med Oncol, Med Ctr, Leiden, Netherlands

[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Surg Oncol, Amsterdam, Netherlands

[3] Vrije Univ, Med Oncol, Med Ctr, Amsterdam, Netherlands

[4] Maastricht Univ, Med Oncol, Med Ctr, Maastricht, Netherlands

[5] Zuyderland Med Ctr, Med Oncol, Heerlen, Netherlands

[6] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands

[7] Isala Hosp, Med Oncol, Zwolle, Netherlands

[8] Radboud Univ Nijmegen, Med Oncol, Med Ctr, Nijmegen, Netherlands

[9] Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands

[10] Med Spectrum Twente, Med Oncol, Enschede, Netherlands

[11] Med Ctr Leeuwarden, Med Oncol, Leeuwarden, Netherlands

[12] Univ Med Ctr Utrecht, Med Oncol, Utrecht, Netherlands

[13] Amphia Ziekenhuis, Med Oncol, Breda, Netherlands

[14] Erasmus MC, Med Oncol, Rotterdam, Netherlands

[15] Maxima Med Ctr, Med Oncol, Veldhoven, Netherlands

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1276P

引用

页数：1

共 50 条

[1] Efficacy and safety of anti-PD1 agents in patients with advanced GI malignancies: Real-world data
Montenegro Luis, S.
Garcia-Torralba, E.
Vicente Conesa, M.
Ricote Sanchez, G.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S80 - S80
[2] Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study
van Zeijl, Michiel C. T.
Haanen, John B. A. G.
Wouters, Michel W. J. M.
de Wreede, Liesbeth C.
Jochems, Anouk
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
de Groot, Jan Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen W.
Piersma, Djura
van Rijn, Rozemarijn S.
Suijkerbuijk, Karijn P. M.
ten Tije, Albert J.
van der Veldt, Astrid A. M.
Vreugdenhil, Gerard
van der Hoeven, Koos J. M.
van den Eertwegh, Alfons J. M.
[J]. JOURNAL OF IMMUNOTHERAPY, 2020, 43 (08) : 256 - 264
[3] Real-world efficacy of anti-PD-1 antibodies in advanced acral melanoma patients: A retrospective, multicenter study (JAMP study).
Nakamura, Yasuhiro
Namikawa, Kenjiro
Yoshino, Koji
Yoshikawa, Shusuke
Uchi, Hiroshi
Goto, Katsunobu
Nakamura, Yoshiyuki
Fukushima, Satoshi
Kiniwa, Yukiko
Takenouchi, Tatsuya
Uhara, Hisashi
Kawai, Toru
Hatta, Naohito
Funakoshi, Takeru
Teramoto, Yukiko
Otsuka, Atsushi
Doi, Haruki
Ogata, Dai
Matsushita, Shigeto
Yamazaki, Naoya
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[4] SAFETY AND EFFICACY OF ANTI-PD1 ANTIBODIES IN THE ELDERLY POPULATION WITH METASTATIC MELANOMA AT THE CANBERRA HOSPITAL
Randhawa, M.
Rai, R.
Nguyen, B.
Ali, S.
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 67 - 67
[5] ANTI-JO1 ANTIBODIES IN A REAL-WORLD POPULATION.
Greco, M.
Garcia de Yebenes, M. J.
Novoa Medina, F. J.
Hernandez Beriain, J. A.
Riano Ruiz, M. M.
Montesa, M. J.
Rua-Figueroa, I.
Loza, E.
Carmona, L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1582 - 1582
[6] Anti-PD1 antibodies in late elderly advanced melanoma patients: A retrospective multicentre study.
De Rosa, Francesco
Ridolfi, Laura
Tanda, Enrica Teresa
Marra, Elena
Pigozzo, Jacopo
Marconcini, Riccardo
Guida, Michele
Gallizzi, Giulia
Occelli, Marcella
Pala, Laura
Gambale, Elisabetta
Bersanelli, Melissa
Conca, Raffaele
Cortellini, Alessio
Morgese, Francesca
Zoratto, Federica
Stucci, Luigia Stefania
Strippoli, Sabino
Petracci, Elisabetta
Guidoboni, Massimo
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[7] Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy
Egeler, Mees
Lai-Kwon, Julia
Tissier, Renaud
Fraterman, Itske
Kuijpers, Anke
Van Houdt, Winan
Wilgenhof, Sofie
Rao, Aparna
Sandhu, Shahneen
Lee, Rebecca
Eriksson, Hanna
van Leeuwen, Marieke
de Ligt, Kelly
van Akkooi, Alexander
van de Poll-Franse, Lonneke
[J]. EUROPEAN JOURNAL OF CANCER, 2024, 200
[8] Mortality prediction in real world advanced melanoma patients treated by anti-PD1 within MelBase, a French multicentric prospective cohort
Oriano, B.
Dalle, S.
Mortier, L.
Dutriaux, C.
Dereure, O.
Leccia, M-T.
Dalac, S.
Legoupil, D.
De Quatrebarbes, J.
Montaudie, H.
Arnault, J. P.
Possenti, F. Brunet
Saiag, P.
Maubec, E.
Lesimple, T.
Aubin, F.
Granel-Brocard, F.
Dreno, B.
Porcher, R.
Lebbe, C.
[J]. ANNALS OF ONCOLOGY, 2020, 31 : S751 - S751
[9] REAL-WORLD OUTCOMES OF IPILIMUMAB IN PATIENTS WITH ADVANCED MELANOMA IN THE NETHERLANDS
Leeneman, B.
Jochems, A.
Schouwenburg, M.
Aarts, M.
van Akkooi, A.
van den Berkmortel, F.
van den Eertwegh, A.
Groenewegen, G.
de Groot, J.
Haanen, J.
van der Hoeven, J.
Hospers, G.
Kapiteijn, H.
Koornstra, R.
Kruit, W.
Louwman, M.
Piersma, D.
van Rijn, R.
ten Tije, A.
Vreugdenhil, G.
Wouters, M.
van Zeijl, M.
Franken, M.
Uyl-de Groot, C.
[J]. VALUE IN HEALTH, 2016, 19 (07) : A708 - A709
[10] Real-world outcomes of advanced melanoma patients not represented in phaseIIItrials
van Zeijl, Michiel C. T.
Ismail, Rawa K.
de Wreede, Liesbeth C.
van den Eertwegh, Alfonsus J. M.
de Boer, Anthonius
van Dartel, Maaike
Hilarius, Doranne L.
Aarts, Maureen J. B.
van den Berkmortel, Franchette W. P. J.
Boers-Sonderen, Marye J.
de Groot, Jan-Willem B.
Hospers, Geke A. P.
Kapiteijn, Ellen
Piersma, Djura
van Rijn, Rozemarijn S.
Suijkerbuijk, Karijn P. M.
ten Tije, Albert J.
van der Veldt, Astrid A. M.
Vreugdenhil, Gerard
Haanen, John B. A. G.
Wouters, Michel W. J. M.
[J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (12) : 3461 - 3470

← 1 2 3 4 5 →